Healthcare Solutions
  |  
Transformation Services
  |  
Healthcare Communities
  |  
News and Events
  |  
About Us
  |  
Careers
 
 
TELUS Health eNewsletters
Ad box text for Pharmacy management landing page Continuum and IV are designed to keep you informed and current with what we're up to across the continuum of care.

Media Releases
2012
2011
2010
2009
2008
2007
 
Media Releases

UT Southwestern Medical Center activates Java™ version of Oacis electronic patient record system


Montréal, February 6, 2007 — Emergis Inc. (TSX: EME) announced today that UT Southwestern Medical Center has successfully activated the Java™ version of Oacis – the company's interoperable electronic patient record system and enterprise master patient Index (EMPI). UT Southwestern chose to upgrade its Oacis applications to support their goal of effortless online access to electronic patient records, irrespective of care delivery setting or the location of attending clinicians.

“With the addition of UT Southwestern, there are now 20 sites in North America which have successfully upgraded to the Java version of Oacis, with more in progress in Australia,” commented Mark Groper, Executive Vice-President at Emergis. “This is a remarkable accomplishment considering the Java version has been available for only eighteen months. Furthermore, it's a strong testament to the unique combination of Oacis' clinician-driven design, efficient web deployment, and open architecture designed for interoperability.”

UT Southwestern ranks among the top academic medical centers in the world. Its faculty members, who are responsible for a broad array of groundbreaking biomedical research advances, are respected for their dedication to teaching and training. The Oacis implementation throughout UT Southwestern encompasses Parkland Health & Hospital System as well as UT Southwestern University Hospital.

The Oacis Solution
Oacis' flexible open architecture design enables it to support a variety of settings. It can link and integrate patient information among disparate systems, as well as provide care delivery organizations with full-function EMR functionality. It can also be packaged as an EHR platform for communities and regions.

Oacis boasts a history of firsts. The product's early roots helped launch the HL7® Standards Development Organization and it was the first commercially viable clinical data repository (CDR)-based patient record solution designed to interconnect with other systems. Moreover, its unique “smart summarization” and drill-down user interface have been emulated by numerous suppliers, but never fully replicated. More recently, Oacis became the first Java-based (fully web enabled) solution available, resulting in enhanced flexibility and value for clients. Among the numerous advantages of Java, it enables care providers to use Oacis on all Internet-capable devices, including Apple's Macintosh, a requirement of most university medical centers.

The flexibility of the Oacis CDR enables it to be configured as a central data model for enterprise and local EHR deployments as well as accommodate confederated models often required by larger jurisdictions. Oacis interconnects the various EMRs and other systems across all sites through a common EMPI and CDR. All clinicians use the Oacis Clinical Viewer application to access and view longitudinal EHR data spanning the organizations' dispersed locations and numerous information systems.

About Emergis
Emergis is an IT leader that focuses on the health and financial services sectors. It develops and manages solutions that automate transactions and the exchange of information to increase the process efficiency and quality of service of its customers. Emergis has expertise in electronic health-related claims processing, health record systems, pharmacy management solutions, cash management and loan document processing and registration. In Canada, Emergis and its subsidiaries deliver solutions to the main insurance companies, top financial institutions, government agencies, hospitals, large corporations, real estate lawyers and notaries, and approximately 40% of all pharmacies. The Company's shares (TSX: EME) are included in the S&P/TSX Composite Index.

Certain information in this news release, in various filings with Canadian regulators, in reports to shareholders and in other communications, is forward-looking within the meaning of certain securities laws, and is subject to important risks, uncertainties and assumptions. This forward-looking information includes, among others, information with respect to the Company's objectives and the strategies to achieve those objectives, as well as information with respect to the Company's beliefs, plans, expectations, anticipations, estimates and intentions. The words “may”, “could”, “should”, “would”, “suspect”, “outlook”, “believe”, “anticipate”, “estimate”, “expect”, “intend”, “plan”, “target” and similar words and expressions are used to identify forward-looking information. The forward-looking information in this news release describes the Company's expectations as of February 6, 2007.

The results or events predicted in such forward-looking information may differ materially from actual results or events. Material factors which could cause actual results or events to differ materially from a conclusion, forecast or projection in such forward-looking information include, among others: general economic factors, adverse industry events, the adoption rate of the Company's solutions by customers and by related electronic trading communities, the delivery delays or failures, non-renewal of major contracts which expire in the near term, complexities and the timing of signing government contracts, customers developing internally the capability to perform the services which the Company performs on their behalf, the Company's response to its industry's rapid rate of change, the limited time available to capitalize on market opportunities, competition, pricing pressures, fluctuations in its operating results, its ability to make and integrate acquisitions, exposure under contract indemnities, defects in software or failures in the processing of transactions, security and privacy breaches, the Company's ability to attract and retain key personnel, its ability to protect its intellectual property, intellectual property infringement claims, and industry and government regulation.

Emergis cautions that the foregoing list of material factors is not exhaustive. When relying on the Company's forward-looking information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. In making the forward-looking information contained in this news release, the Company does not assume any significant acquisitions, dispositions or one-time items. It does assume, however, the renewal of certain customer contracts. Every year, Emergis has major customer contracts that it needs to renew. Some of these may represent slightly more than 10% of its annual revenue. In addition, the Company also assumes the signature of contracts in new markets in the public health sector. In this regard, Emergis is pursuing large opportunities that present a very long and complex sales cycle, which substantially affect the Company's forecasting abilities. The Company has made certain assumptions regarding the timing of the realization of these opportunities which it thinks is reasonable but which may not be achieved. Furthermore, the pursuit of these larger opportunities does not ensure a linear progression of the Company's revenue and earnings, since they may involve significant up-front fees followed by reduced ongoing payments. The Company has assumed a certain progression, which may not be realized. It has also assumed that the material factors referred to in the previous paragraph will not result in such forward-looking information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. For additional information with respect to certain of these and other factors, refer to the risks and uncertainties section of the MD&A in the Company's 2005 Annual Report and to its 2005 Annual Information Form (risks and uncertainties) filed with Canadian regulators.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF EMERGIS AS AT February 6, 2007 AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. HOWEVER, EMERGIS EXPRESSLY DISCLAIMS ANY INTENTION OR OBLIGATION TO UPDATE OR REVISE ANY FORWARD-LOOKING INFORMATION, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE, EXCEPT AS REQUIRED BY APPLICABLE LAW.